{"article": [{"url": "https://www.marketwatch.com/story/abiomeds-stock-rises-on-second-covid-19-related-eua-for-heart-pump-2020-08-04", "published": 1596527780.0, "headline": "Abiomed's stock rises on second COVID-19-related EUA for heart pump", "body": "Shares of Abiomed Inc. ABMD, +0.87% rallied 2.0% in premarket trading on Tuesday after the company said its Impella heart pump had received an emergency use authorization from the Food and Drug Administration as a treatment for some COVID-19 patients. The heart pump can be used for patients who have heart or lung damage as a result of an infection with the coronavirus. This is the second time the FDA has authorized the pump for use in COVID-19 patients; in May, the FDA issued an EUA for patients suffering from COVID-19-related right ventricular complications. Abiomed's stock is up 80.7% year-to-date, while the S&P 500 SPX, +0.87% is up 1.9%."}]}